Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has entered into a sales distributing contract with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai"). The contract grants Huahai the priority rights to sell BON's broccoli products in the Chinese market with a total product value of US$45 million.

BON's most recent broccoli product, Broclife, represents the Company's advancement in converting glucoraphanin to sulforaphane in broccoli extracts. Broclife utilizes broccoli seed extract as the core active ingredient and offers various health benefits in areas of immunity, anti-oxidation, anti-aging, anti-inflammatory and digestive health.

"We are excited to work with Huahai on this product distribution partnership. Huahai is a leading wellness company in China that focuses on the go-to-market of original wellness products with a proven track record of expanding markets and developing strong brands. This represents an opportunity for us to gain the broader access to the extensive retail market in China," commented Yongwei Hu, Chairman and CEO of BON. "Our strategic cooperation with Huahai, combined with our exceptional Broclife product, will help BON quickly penetrate the health markets. This breakthrough marks a significant advancement in our end-to-end health solution business and will propel the global expansion of our broccoli raw material business. We expect these initiatives to significantly boost sales and profit growth, enhancing the company's investment value and generating greater returns for our shareholders."